Accessibility Statement
Skip to main content
Lilly.com
Investors
Contact
Globe
Menu
Menu
Menu closed
Close
Close
Our Strategy
Expand mega menu
Expand submenu
Collapse Our Strategy
Our Strategy
Expand
ESG Strategy
ESG Goals
CEO Letter
About This Report
Latest ESG Developments
Environmental
Expand mega menu
Expand submenu
Collapse Environmental
Environmental
Expand
Our Approach and Goals
Expand
Climate
Waste
Water
Product Stewardship
Social
Expand mega menu
Expand submenu
Collapse Social
Social
Expand
Our Approach and Goals
Expand
Access & Affordability
Community Engagement
Diversity, Equity & Inclusion
Employee Well-Being
Human Rights
Patient Safety
Governance
Expand mega menu
Expand submenu
Collapse Governance
Governance
Expand
Our Approach
Expand
Business Ethics
Corporate Governance
Supply Chain Management
Transparency
Expand mega menu
Expand submenu
Collapse Transparency
Transparency
Expand
ESG Metrics
SASB Index
Expand
SDGs
TCFD
Expand
UNGC Index
Reports & Policies
Lilly.com
Investors
Contact
Globe
Researching Medicines in a Diverse World
Eli Lilly and Company
| June 1, 2022
Tags |
ESG
Loading...
Loading...
Loading...
Loading...
